HIV/AIDS

12 October 2004

New developments in medications

New drugs as well as new categories of drugs are being developed all the time.

0

New drugs as well as new categories of drugs are being developed all the time.

One of the latest developments reported at the Aids conference in Barcelona, is to target the first step in the virus cycle, namely virus entry. Fusion inhibitor - T20 prevents HIV from entering the host cell by affecting the interactions between the virus and the cell. It stops the viral proteins gp120 and gp41 from forming a stable interaction with the CD4 molecule. The virus is thus unable to fuse with the cell (binding, fusion and entry are blocked). These drugs are still in developmental and testing phases.

Other drugs in the developmental phase are Integrase inhibitors. These drugs are developed to prevent the process by which HIV integrates into the host cell core. The virus is unable to replicate unless it is integrated into the host’s DNA and so cannot infect further cells.

Read more:
Watch out for these flu complications
Who are most at risk for flu complications?

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Add your comment
Comment 0 characters remaining

Ask the Expert

HIV/Aids expert

Dr Sindisiwe van Zyl qualified at the University of Pretoria before working for an HIV/AIDS NPO in Soweto for many years. She was named one of the Mail & Guardian's Top 200 Young South Africans in 2012.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules